Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Wnt/β-catenin

Items 31-40 of 40

Page
per page
  1. JW 55
    A4529 JW 55
    Summary: PARP domain inhibitor
      insoluble in H2O; ≥19.25 mg/mL
  2. KY 02111
    A8213 KY 02111
    Summary: WNT signaling inhibitor
      insoluble in H2O; ≥18.85 mg/mL
  3. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  4. Wnt agonist 1
    B6059 Wnt agonist 1
     1 Citation
    Summary: agonist of Wnt signaling pathway
      ≥38.7 mg/mL
  5. FH535
    A3413 FH535
    Summary: Wnt/B-catenin inhibitor
      ≥36.1 mg/mL
  6. Salinomycin
    A3785 Salinomycin
    Target: Antibiotic
    Summary: Polyether ionophore antibiotic;anti-cancer
  7. (E)-Ferulic acid
    C6800 (E)-Ferulic acid
      ≥36.7 mg/mL
  8. IWP-3
    C3254 IWP-3
    Summary: inhibitor of Wnt production
      ≤0.1 mg/mL
  9. IWP-2-V2
    C3625 IWP-2-V2
    Summary: Wnt production inhibitor
      ≤2 mg/mL
  10. HLY78
    C5433 HLY78
    Summary: positive modulator of the Wnt/β-catenin pathway
      ≤2 mg/mL

Items 31-40 of 40

Page
per page